Lloreda Camacho & Co.

According to many, Lloreda Camacho & Co. is ‘the must-go-to team for life sciences within the Colombian market’. Acting for an enviable portfolio of major domestic and multinational pharmaceutical, healthcare, cosmetics, medical devices and food and beverage companies, the group continues to grow its market share and added Becton Dickinson and Galderma — among numerous others — to its roster during 2024/25. Department head Ana María Castro is hailed by clients as an ’A+ life sciences expert’; she provides ongoing advice to a string of global pharma corporations on patent work — including Gilead Sciences and Incyte — and she also advises on regulatory matters. Daniel Cardona specialises in health legislation, where he contributes ‘deep understanding of the scientific and technical aspects of the sector’; he advises on an array of regulatory compliance matters including new products, advertising, competition and consumer protection-related issues. The practice further draws on regulatory partner Enrique Álvarez, whose work encompasses life sciences, competition and data privacy law. At senior associate level, sources highlight ’outstanding professional’ Paula Romero, who stands out for her specialist focus on regulatory, sanctioning and health system law. In June 2025, associate director María Alejandra De Los Ríos left to join Sanofi.